These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31959703)

  • 21. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters.
    Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T
    Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.
    Ohtsuki S; Schaefer O; Kawakami H; Inoue T; Liehner S; Saito A; Ishiguro N; Kishimoto W; Ludwig-Schwellinger E; Ebner T; Terasaki T
    Drug Metab Dispos; 2012 Jan; 40(1):83-92. PubMed ID: 21994437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.
    Rowland A; Ruanglertboon W; van Dyk M; Wijayakumara D; Wood LS; Meech R; Mackenzie PI; Rodrigues AD; Marshall JC; Sorich MJ
    Br J Clin Pharmacol; 2019 Jan; 85(1):216-226. PubMed ID: 30340248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.
    Vaessen SF; van Lipzig MM; Pieters RH; Krul CA; Wortelboer HM; van de Steeg E
    Drug Metab Dispos; 2017 Apr; 45(4):353-360. PubMed ID: 28153842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro.
    van de Kerkhof EG; de Graaf IA; Ungell AL; Groothuis GM
    Drug Metab Dispos; 2008 Mar; 36(3):604-13. PubMed ID: 18094037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
    Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
    Clin Pharmacol Ther; 2019 May; 105(5):1204-1212. PubMed ID: 30447067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides.
    Kazmi F; Yerino P; McCoy C; Parkinson A; Buckley DB; Ogilvie BW
    Drug Metab Dispos; 2018 Aug; 46(8):1066-1074. PubMed ID: 29735754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in quantitative methods based on liquid chromatography-mass spectrometry for drug metabolizing enzymes in human liver microsomes].
    Wang H; Lu Y; Peng B; Qian X; Zhang Y
    Se Pu; 2015 Jun; 33(6):553-7. PubMed ID: 26536756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics.
    Al-Majdoub ZM; Scotcher D; Achour B; Barber J; Galetin A; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2021 Nov; 110(5):1389-1400. PubMed ID: 34390491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.
    Mamidi RNVS; Dallas S; Sensenhauser C; Lim HK; Scheers E; Verboven P; Cuyckens F; Leclercq L; Evans DC; Kelley MF; Johnson MD; Snoeys J
    Br J Clin Pharmacol; 2017 May; 83(5):1082-1096. PubMed ID: 27862160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human.
    Basit A; Neradugomma NK; Wolford C; Fan PW; Murray B; Takahashi RH; Khojasteh SC; Smith BJ; Heyward S; Totah RA; Kelly EJ; Prasad B
    Mol Pharm; 2020 Nov; 17(11):4114-4124. PubMed ID: 32955894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics.
    Couto N; Al-Majdoub ZM; Achour B; Wright PC; Rostami-Hodjegan A; Barber J
    Mol Pharm; 2019 Feb; 16(2):632-647. PubMed ID: 30608694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity.
    Achour B; Dantonio A; Niosi M; Novak JJ; Fallon JK; Barber J; Smith PC; Rostami-Hodjegan A; Goosen TC
    Drug Metab Dispos; 2017 Oct; 45(10):1102-1112. PubMed ID: 28768682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity.
    Krogstad V; Peric A; Robertsen I; Kringen MK; Wegler C; Angeles PC; Hjelmesæth J; Karlsson C; Andersson S; Artursson P; Åsberg A; Andersson TB; Christensen H
    Drug Metab Dispos; 2020 Jan; 48(1):8-17. PubMed ID: 31685482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.
    Akazawa T; Uchida Y; Miyauchi E; Tachikawa M; Ohtsuki S; Terasaki T
    Mol Pharm; 2018 Jan; 15(1):127-140. PubMed ID: 29140712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?
    Isoherranen N; Thummel KE
    Drug Metab Dispos; 2013 Feb; 41(2):256-62. PubMed ID: 23328895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.